Namandje Bumpus Insider Trades & Stock Holdings
Namandje Bumpus at Recursion Pharmaceuticals, Inc. has 1 Form 4 trade on file since Jun 18, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($12.60K), net -$12.60K. Latest filing: disposed of 3.96K shares of $RXRX on Jun 18, 2026 at $3.18.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $12.60K
- Net open-market
- -$12.60K
- Latest filing
- Jun 18, 2026
All insider trades by Namandje Bumpus
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $RXRX | Sell (Open-market sale) 10b5-1 | 3.96K | $3.18 | $12.60K | +3.4% | -10.5% | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Namandje Bumpus traded
Frequently asked questions
Has Namandje Bumpus been buying or selling stock?
Namandje Bumpus has 0 open-market purchases and 1 open-market sale on file, net -$12.60K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Namandje Bumpus's latest insider trade?
disposed of 3.96K shares of $RXRX on Jun 18, 2026 at $3.18.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.